Apogee Therapeutics, Inc. · NASDAQ:APGE

Henderson Michael Thomas sold 20,000 Apogee Therapeutics, Inc. shares (Form 4)

Traded May 13, 2026 · Filed May 15, 2026

On May 13, 2026, Henderson Michael Thomas (Director, Chief Executive Officer) sold 20,000 Apogee Therapeutics, Inc. shares at an average US$82.09 for US$1.64M under a trading plan, leaving 1,115,987 shares. Filed May 15, 2026 (Form 4).

Sold
20,000 shares
Price
US$82.09 average (US$82.05 to US$82.58)
Value
US$1.64M
Holding after
1,115,987 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 13, 2026Common StockSale18,659US$82.051,117,328Direct
May 13, 2026Common StockSale1,341US$82.581,115,987Direct

Source

View original at SEC

Related